[go: up one dir, main page]

HK1258305A1 - 含有抗白介素-4受體(il-4r)的抗體的穩定製劑 - Google Patents

含有抗白介素-4受體(il-4r)的抗體的穩定製劑

Info

Publication number
HK1258305A1
HK1258305A1 HK19100671.5A HK19100671A HK1258305A1 HK 1258305 A1 HK1258305 A1 HK 1258305A1 HK 19100671 A HK19100671 A HK 19100671A HK 1258305 A1 HK1258305 A1 HK 1258305A1
Authority
HK
Hong Kong
Prior art keywords
interleukin
antibodies
receptor
formulations containing
containing anti
Prior art date
Application number
HK19100671.5A
Other languages
English (en)
Chinese (zh)
Inventor
Daniel B Dix
Xiaolin Tang
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of HK1258305A1 publication Critical patent/HK1258305A1/zh

Links

HK19100671.5A 2010-10-06 2019-01-15 含有抗白介素-4受體(il-4r)的抗體的穩定製劑 HK1258305A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39028310P 2010-10-06 2010-10-06

Publications (1)

Publication Number Publication Date
HK1258305A1 true HK1258305A1 (zh) 2019-11-08

Family

ID=45995014

Family Applications (1)

Application Number Title Priority Date Filing Date
HK19100671.5A HK1258305A1 (zh) 2010-10-06 2019-01-15 含有抗白介素-4受體(il-4r)的抗體的穩定製劑

Country Status (14)

Country Link
AR (1) AR083338A1 (pt)
DK (2) DK2624865T3 (pt)
ES (2) ES2820246T3 (pt)
HK (1) HK1258305A1 (pt)
HR (1) HRP20181822T1 (pt)
HU (1) HUE052089T2 (pt)
LT (1) LT2624865T (pt)
PT (1) PT3354280T (pt)
RS (1) RS57850B1 (pt)
SI (1) SI2624865T1 (pt)
SM (1) SMT201800488T1 (pt)
TW (7) TWI498121B (pt)
UA (1) UA111731C2 (pt)
UY (1) UY33652A (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015003590A8 (pt) 2012-08-21 2017-10-31 Sanofi Sa Métodos para tratamento ou prevenção da asma por administração de um antagonista de il-4r
HUE046410T2 (hu) * 2013-06-21 2020-03-30 Sanofi Biotechnology Eljárások orrpolipózis kezelésére IL-4R-antagonista beadásával
AU2014284235B2 (en) * 2013-06-21 2019-11-21 Regeneron Pharmaceuticals, Inc. Methods for treating nasal polyposis by administering an IL-4R antagonist
WO2016077675A1 (en) 2014-11-14 2016-05-19 Sanofi Biotechnology Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist
PL3703818T3 (pl) 2017-10-30 2024-03-25 Sanofi Biotechnology Antagonista IL-4R do zastosowania w sposobie leczenia lub zapobiegania astmie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
ES2332082B1 (es) * 2008-07-24 2010-10-26 Consejo Superior De Investigaciones Cientificas (Csic) 45% Sistema de alineacion de patrones en un sustrato mediante litografia por estencil.
KR101593726B1 (ko) * 2008-09-10 2016-02-18 니혼 엑스란 고교 (주) 가교 아크릴레이트계 섬유 및 이의 제조방법
CA2754528A1 (en) * 2009-03-06 2010-09-10 Genetech, Inc. Antibody formulation

Also Published As

Publication number Publication date
TW201716086A (zh) 2017-05-16
TW202320851A (zh) 2023-06-01
PT3354280T (pt) 2020-09-01
HUE052089T2 (hu) 2021-04-28
DK3354280T3 (da) 2020-09-28
SMT201800488T1 (it) 2018-11-09
TW202026011A (zh) 2020-07-16
TWI690329B (zh) 2020-04-11
TW202102262A (zh) 2021-01-16
UY33652A (es) 2012-04-30
TWI856388B (zh) 2024-09-21
TW201221141A (en) 2012-06-01
RS57850B1 (sr) 2018-12-31
ES2687813T3 (es) 2018-10-29
HRP20181822T1 (hr) 2018-12-28
ES2820246T3 (es) 2021-04-20
TWI718890B (zh) 2021-02-11
TW201542229A (zh) 2015-11-16
TWI498121B (zh) 2015-09-01
TWI782325B (zh) 2022-11-01
SI2624865T1 (sl) 2018-10-30
TWI679988B (zh) 2019-12-21
DK2624865T3 (en) 2018-10-22
TW201924718A (zh) 2019-07-01
AR083338A1 (es) 2013-02-21
LT2624865T (lt) 2018-10-25
UA111731C2 (uk) 2016-06-10
TWI568445B (zh) 2017-02-01

Similar Documents

Publication Publication Date Title
IL283424B1 (en) Stabilized formulations that include antibodies against the interleukin receptor (il-4r)
HRP20181821T1 (hr) Stabilizirani pripravci koji sadrže anti-interleukin-6 receptorska (il-6r) antitijela
IL265501A (en) Stabilized liquid formulations containing antibody
RS61082B1 (sr) Stabilno antitelo koje sadrži kompozicije
HK1258305A1 (zh) 含有抗白介素-4受體(il-4r)的抗體的穩定製劑
EP2588141A4 (en) ANTIBODY FORMULATIONS